FindTrial
Sign In

Molecular mechanism study of protein post-translational multi modification omics detection based on mass spectrometry for the development of papillary thyroid carcinoma

Molecular mechanism study of protein post-translational multi modification omics detection based on mass spectrometry for the development of papillary thyroid carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400088586
Enrollment
Unknown
Registered
2024-08-21
Start date
2024-06-06
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

papillary thyroid carcinoma

Interventions

cancerous and adjacent tissues of papillary thyroid carcinoma:No
Cancer tissue of papillary thyroid carcinoma patients:No

Sponsors

Second People’s Hospital of Shenzhen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with papillary thyroid cancer who have signed a sample donation consent form and their tissue specimens have been stored in the biological specimen library

Exclusion criteria

Exclusion criteria: Patients who do not agree to sample donation

Design outcomes

Primary

MeasureTime frame
Differential expression of proteins in the cancerous and adjacent tissues of papillary thyroid carcinoma;Differential expression of protein post-translational modifications in the cancerous and adjacent tissues of papillary thyroid carcinoma;—

Secondary

MeasureTime frame
The relationship between differences in post-translational modifications of papillary thyroid carcinoma proteins and the risk stratification of papillary thyroid carcinoma recurrence;—

Countries

China

Contacts

Public ContactYongtian Lu

Shenzhen Second People's Hospital

luyongtian@263.net+86 136 0266 6223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026